Your browser doesn't support javascript.
loading
Optimization of additive chemotherapy combinations for an in vitro cell cycle model with constant drug exposures.
Cardilin, Tim; Lundh, Torbjörn; Jirstrand, Mats.
Afiliação
  • Cardilin T; Fraunhofer-Chalmers Research Centre for Industrial Mathematics, Gothenburg, Sweden; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden. Electronic address: tim.cardilin@fcc.chalmers.se.
  • Lundh T; Department of Mathematical Sciences, Chalmers University of Technology and University of Gothenburg, Gothenburg, Sweden.
  • Jirstrand M; Fraunhofer-Chalmers Research Centre for Industrial Mathematics, Gothenburg, Sweden.
Math Biosci ; 338: 108595, 2021 08.
Article em En | MEDLINE | ID: mdl-33831415
Proliferation of an in vitro population of cancer cells is described by a linear cell cycle model with n states, subject to provocation with m chemotherapeutic compounds. Minimization of a linear combination of constant drug exposures is considered, with stability of the system used as a constraint to ensure a stable or shrinking cell population. The main result concerns the identification of redundant compounds, and an explicit solution formula for the case where all exposures are nonzero. The orthogonal case, where each drug acts on a single and different stage of the cell cycle, leads to a version of the classic inequality between the arithmetic and geometric means. Moreover, it is shown how the general case can be solved by converting it to the orthogonal case using a linear invertible transformation. The results are illustrated with two examples corresponding to combination treatment with two and three compounds, respectively.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclo Celular / Modelos Biológicos / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ciclo Celular / Modelos Biológicos / Antineoplásicos Idioma: En Ano de publicação: 2021 Tipo de documento: Article